Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-004849
Filing Date
2025-03-06
Accepted
2025-03-06 21:08:33
Documents
1
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3454
  Complete submission text file 0001062993-25-004849.txt   5015
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Issuer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ORGANOGENESIS INC. 85 DAN ROAD CANTON MA 02021
Business Address
Driscoll Michael Joseph (Reporting) CIK: 0001912097 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37906 | Film No.: 25717354